As ovarian cancer associates with breast cancer, the patients are analyzed by overlapping or identical NGS panels and thus ovarian cancer patients probably represent the largest cancer group explored for mutations in the CHEK2 gene just after breast cancer patients. This evidence concerns the gene CHEK2 and ovarian cancer.